Tech Company Financing Transactions

XLumena Funding Round

XLumena secured a $25 million Series C funding round on 12/3/2013. Backers included Third Point, Aperture Venture Partners and Ascent Biomedical Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

453 Ravendale Dr. H
Mountain View, CA 94043
USA

Phone

(650) 961-9900

Website

www.xlumena.com

Email Address

[email protected]

Overview

Xlumena is the leader in the developments of image-guided therapeutic endoscopy products specializing in advanced implants and devices that address multiple markets. Collaborating with top physicians in the field, Xlumena focuses on technology that advances therapy to the next level.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Greg Patterson

        

Chief Medical Officer

Kenneth Binmoeller

        

VP - Operations

Mark Scratch

        

VP - R & D

Peter Brown

        

VP - Regulatory Affairs

Jane Beggs

        

Browse more venture capital transactions:

Prev: 12/3/2013: Blaze Bioscience venture capital transaction
Next: 12/3/2013: Payoff venture capital transaction

Share this article

About Our VC Transactions Data

We document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary